Industry News

Global Intraocular Lens Market to Reach $6.7 Billion by 2032, FMR Report Shows

The global intraocular lens market is projected to grow from its current valuation of $4.1 billion to $6.7 billion by the end of 2032, according to a recent report by Fact Market Research (FMR).

Global Intraocular Lens Market to Reach $6.7 Billion by 2032, FMR Report Shows
January 31, 2023
Corcoran Consulting and Conclusn Develop App for Ophthalmology Practice Management

Corcoran Consulting Group (CCG) and Conclusn have teamed up to create a software application that provides proprietary utilization benchmarks for ophthalmic procedures.

Corcoran Consulting and Conclusn Develop App for Ophthalmology Practice Management
January 26, 2023
TFS HealthScience Acquires Appletree CI Group, Expanding Presence in Ophthalmology

Contract research organization TFS HealthScience announced it has acquired Appletree CI Group, a CRO and global regulatory affairs service provider. The terms of the deal were not disclosed.

TFS HealthScience Acquires Appletree CI Group, Expanding Presence in Ophthalmology
January 25, 2023
Topcon Receives ISO 27001 Certification of its Harmony RS Clinical Data Management System

Topcon Healthcare has received ISO 27001 certification of its Harmony RS Clinical Data Management System. ISO 27001 is a globally recognized standard for the establishment and certification of an information security management system (ISMS).

Topcon Receives ISO 27001 Certification of its Harmony RS Clinical Data Management System
January 19, 2023
STADA and Xbrane Receive British Approval for Ximluci® (Ranibizumab)

STADA Arzneimittel AG and Xbrane Biopharma AB announced that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ximluci® (ranibizumab), a biosimilar of Lucentis®. STADA plans to launch Ximluci in the United Kingdom in 2023.

STADA and Xbrane Receive British Approval for Ximluci® (Ranibizumab)
January 17, 2023
Glaukos: iDose TR Implant Demonstrates Favorable Safety and Tolerability

Glaukos announced positive results for a prospective, multicenter clinical trial designed to assess the safety of the surgical exchange procedure for iDose TR (travoprost intraocular implant) in subjects who had previously received an iDose TR.

Glaukos: iDose TR Implant Demonstrates Favorable Safety and Tolerability
January 16, 2023
Rayner Introduces ‘Peer2Peer: The Podcast’ for Clinical Education

Rayner has announced the release of "Peer2Peer: The Podcast," the latest edition of their Peer2Peer clinical education platform.

Rayner Introduces ‘Peer2Peer: The Podcast’ for Clinical Education
January 13, 2023
Market Scope: Refractive Surgery Market Will Reach $12 Billion in 2027

According to Market Scope’s recent report, the global refractive surgery market will generate $12 billion in total retail revenue in 2027, up from $8.9 billion in 2022, representing a 6.2% compound growth rate.

Market Scope: Refractive Surgery Market Will Reach $12 Billion in 2027
January 12, 2023
Keranova Announces Positive Clinical Study Results for Robotic Laser Technology

Keranova announced the completion of regulatory clinical tests for its robotic laser technology, FemtoMatrix. Following the positive results, the company said that it will file for CE marking for this new class of surgical equipment in cataract surgery.

Keranova Announces Positive Clinical Study Results for Robotic Laser Technology
January 12, 2023
Sifi Signs License Agreement with Avanzanite for Acanthamoeba Keratitis Treatment Akantior

Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries.

Sifi Signs License Agreement with Avanzanite for Acanthamoeba Keratitis Treatment Akantior
January 11, 2023
More